The effect of a single dose of nivolumab prior to isolated limb perfusion for patients with in-transit melanoma metastases: An interim analysis of a phase Ib/II randomized double-blind placebo-controlled trial (NivoILP trial)-Reference-Cited by-同舟云学术

The effect of a single dose of nivolumab prior to isolated limb perfusion for patients with in-transit melanoma metastases: An interim analysis of a phase Ib/II randomized double-blind placebo-controlled trial (NivoILP trial)

Published:2024-06 Issue:6 Volume:50 Page:108265
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Holmberg Carl-Jacob^ORCID,Zijlker Lisanne P.^ORCID,Katsarelias Dimitrios^ORCID,Huibers Anne E.,Wouters Michel W.J.M.^ORCID,Schrage Yvonne,Reijers Sophie J.M.^ORCID,van Thienen Johannes V.^ORCID,Grünhagen Dirk J.^ORCID,Martner Anna,Nilsson Jonas A.^ORCID,van Akkooi Alexander C.J.,Ny Lars^ORCID,van Houdt Winan J.,Olofsson Bagge Roger^ORCID

Funder

Swedish Cancer Society

Swedish Research Council

Göteborgs Läkaresällskap

Sahlgrenska University Hospital

Goteborgs Universitet Wallenbergcentrum for molekylar och translationell medicin

Publisher

Elsevier BV

Reference29 articles.

1. Predictors and natural history of in-transit melanoma after sentinel lymphadenectomy;Pawlik;Ann Surg Oncol,2005

2. In-transit melanoma metastases: incidence, prognosis, and the role of lymphadenectomy;Read;Ann Surg Oncol,2015

3. Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual;Gershenwald;CA Cancer J Clin,2017

4. The efficacy of immunotherapy for in-transit metastases of melanoma: an analysis of randomized controlled trials;Olofsson Bagge;Melanoma Res,2021

5. The efficacy of immune checkpoint blockade for melanoma in-transit with or without nodal metastases - a multicenter cohort study;Holmberg;Eur J Cancer,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pioneering combination: Nivolumab and isolated limb perfusion in melanoma in-transit metastases treatment;European Journal of Surgical Oncology;2024-12

2. Therapeutic Treatment Options for In-Transit Metastases from Melanoma;Cancers;2024-09-03

3. Reply to: Pioneering combination: Nivolumab and isolated limb perfusion in melanoma in-transit metastases treatment;European Journal of Surgical Oncology;2024-09